Evidence map›Paper›PMID 11178230›Full record

ReviewGenome biology2000

The sequence of human chromosome 21 and implications for research into Down syndrome.

K Gardiner, M Davisson

Open access · bronzeAbstract readReview
In one paragraph

Review in Genome biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Transcriptional consequences of trisomy 21 on neural induction.Frontiers in cellular neuroscience · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Deficits in human trisomy 21 iPSCs and neurons.Proceedings of the National Academy of Sciences of the United States of America · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

K GardinerEleanor Roosevelt Institute, Gaylord Street, Denver, Colorado 80206-1210, USA. gardiner@eri.uchsc.edu
M Davisson
Jackson Laboratory · USRoosevelt Institute · US

Funding

TISSUE CULTURE--COREP01HD017449 · NICHD · UNIVERSITY OF DENVER · PI PATTERSON, DAVID · 1985 to 2003
$5.3M
NICHD NIH HHS HD17449
6 · The paper itself

Abstract

The recent completion of the DNA sequence of human chromosome 21 has provided the first look at the 225 genes that are candidates for involvement in Down syndrome (trisomy 21). A broad functional classification of these genes, their expression data and evolutionary conservation, and comparison with the gene content of the major mouse models of Down syndrome, suggest how the chromosome sequence may help in understanding the complex Down syndrome phenotype.

Indexed as

Gene Expression ProfilingAnimalsChromosomes, Human, Pair 21Conserved SequenceDisease Models, AnimalDown SyndromeHumansMicePhenotypeSequence Homology, Nucleic Acid

Identifiers

PMID11178230
PMCPMC138845
OpenAlexW1488561169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.